What is Cypherpunk Technologies Inc.'s market cap?

Cypherpunk Technologies Inc. (CYPH) has a market capitalization of $74.5M and trades on NASDAQ.

Who are Cypherpunk Technologies Inc.'s competitors?

Cypherpunk Technologies Inc.'s key competitors include MicroStrategy Inc., Novartis, Merck, and others. These companies compete in similar markets and product categories.

Who does Cypherpunk Technologies Inc. partner with?

Cypherpunk Technologies Inc.'s notable partners include Winklevoss Capital, Zcash Open Development Lab (ZODL), Eli Lilly and Company, and others.

What subsidiaries does Cypherpunk Technologies Inc. have?

Cypherpunk Technologies Inc.'s subsidiaries include Leap Therapeutics, Inc., HealthCare Pharmaceuticals Pty Ltd., Leap Securities Corp., and others.

Where is Cypherpunk Technologies Inc. headquartered?

Cypherpunk Technologies Inc. is headquartered in United States of America. It has been publicly traded since 2014.

CYP

Cypherpunk Technologies Inc.

CYPH

Cypherpunk Technologies is a privacy technology company focused on the development and acquisition of privacy-enhancing infrastructure and digital assets.

Market cap

$74.53M+18.5%

Net income-$56.9M+17.7%

EPS (diluted)-$0.02+98.8%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 14, 2026

EPS-$0.46Miss by $0.42

Read the full report

Next report

Aug 13, 2026 (in a month)

EPS estimate-$0.03

Financials

Q1 2026

Income statement

See full

Operating income-$4.8M+69.7%

Net income-$77.2M-400%

EPS (diluted)-$0.46-24.3%

Balance sheet

See full

Cash & equivalents$6.7M-79.6%

Total debt$38.0K-75.3%

Total equity$84.4M+305%

Total assets$87.4M+151%

Cash flow

See full

Operating cash flow-$3.4M+76.3%

Valuation & ratios

Valuation

See full

Market cap$74.53M+18.5%

Enterprise value$67.87M—

Returns & leverage

See full

Return on equity-108.2%-34.4pp

Debt / equity0×0.0×

Current ratio27.3×+24.9×

Competitors

By market cap

Merck & Co.$308.90B+52.1%

Amgen$196.25B+24.6%

Pfizer$138.21B-3.7%

MicroStrategy$33.6B-69.6%

Zscaler$23.8B-51.6%

CNT

Canton Strategic Holdings, Inc. Common Stock$176.6M—

CYP

Cypherpunk Technologies Inc.$74.5M—

MEI Pharma$33.8M+93.5%

By revenue growth

By net margin

MicroStrategy1,663.11%-575pp

Amgen20.96%+3.6pp

Pfizer15.65%+6.3pp

Merck & Co.13.59%-13.7pp

Zscaler-2.44%-0.9pp

CYP

Cypherpunk Technologies Inc.-2,705.8%—

Profile

Cypherpunk Technologies is a privacy technology company focused on the development and acquisition of privacy-enhancing infrastructure and digital assets. The company operates a dual-track strategy: managing a digital asset treasury anchored by Zcash (ZEC) and developing novel biomarker-targeted antibody therapies for cancer through its subsidiary, Leap Therapeutics.

Competitive position

A unique hybrid entity combining a digital asset treasury focused on privacy protocols with a clinical-stage biotechnology pipeline.

GeographiesUnited States, Australia

Customer segmentsBlockchain Ecosystems, Healthcare Institutions, Retail and Institutional Investors

Business modelAsset Treasury, R&D, Licensing

SuppliersZcash Network miners, Contract Manufacturing Organizations (CMOs), Open-source protocol contributors, Clinical trial sites

CustomersDigital asset exchanges, Biopharmaceutical companies, Oncology clinics, Institutional digital asset holders

CountryUnited States of America

Listed2014

CEODouglas E. Onsi

SectorHealthcare

IndustryBiotechnology

Websiteleaptx.com

FilingsSEC EDGAR

Questions, answered.

What is Cypherpunk Technologies Inc.'s market cap?: Cypherpunk Technologies Inc. (CYPH) has a market capitalization of $74.5M and trades on NASDAQ.
Who are Cypherpunk Technologies Inc.'s competitors?: Cypherpunk Technologies Inc.'s key competitors include MicroStrategy Inc., Novartis, Merck, and others. These companies compete in similar markets and product categories.
Who does Cypherpunk Technologies Inc. partner with?: Cypherpunk Technologies Inc.'s notable partners include Winklevoss Capital, Zcash Open Development Lab (ZODL), Eli Lilly and Company, and others.
What subsidiaries does Cypherpunk Technologies Inc. have?: Cypherpunk Technologies Inc.'s subsidiaries include Leap Therapeutics, Inc., HealthCare Pharmaceuticals Pty Ltd., Leap Securities Corp., and others.
Where is Cypherpunk Technologies Inc. headquartered?: Cypherpunk Technologies Inc. is headquartered in United States of America. It has been publicly traded since 2014.